Bookmark and Share

 



Eyes on Trade

Public Citizen's Global Trade Watch blog on globalization and trade

 

What's New - Global Trade Watch


View 'What's New' Archives


Another Broken NAFTA Promise: Challenge by U.S. Corporation Leads Canada to Repeal Public Health Law

Another Broken NAFTA Promise: Challenge by U.S. Corporation Leads Canada to Repeal Public Health Law


Ethyl Wins $13 million Settlement and Repeal of Ban on Controversial Gasoline Additive

What Congress and U.S. consumer and environmental groups were promised could not happen just did: Canada has repealed a national public health law after it was challenged under NAFTA.

The Canadian ban on the gasoline additive MMT was challenged directly under NAFTA rules by MMT's producer, U.S.-based Ethyl Corporation. The corporation was able to bully the sovereign government of Canada into abrogating its duty to protect the health and safety of its citizens.

The case provides the latest evidence that recent international trade and investment agreements are leading to the elimination of important environmental, consumer, health and human rights laws.

In the past two years, the Clinton Administration has pushed through Congress a repeal of a successful dolphin protection after it was threatened with a WTO challenge and weakened reformulated gasoline cleanliness regulations of the Clean Air Act after they were successfully attacked by Venezuela at the WTO.

As well, the Administration has been pressuring state legislatures not to pass human rights laws that might conflict with WTO rules: in Maryland investment and trade sanctions against Nigeria's dictatorship and in Massachusetts measures against the dictatorship of Burma.

In the Ethyl case, Canada repealed its ban on MMT and agreed to pay Ethyl $13 million in order to avoid the $250 million damages Ethyl claimed in its NAFTA suit. Ethyl's challenge to the Canadian law was the first suit initiated under NAFTA provisions that allow corporations in one country to directly sue the government of another country for cash damages.

In April 1997 Canada imposed a ban on the import and interprovincial transport of the gasoline additive MMT. Some U.S. states also ban MMT, whose primary ingredient, manganese, is a known human neurotoxin. Ethyl responded to Canada's public health law with a $250 million lawsuit claiming the law violated its investor protections under NAFTA. Ethyl argued that the law was an "expropriation" of its assets or an action "tantamount to expropriation" because it would eliminate profits Ethyl expected to earn through Canadian sales of the additive.

The Canadian government settled the NAFTA suit yesterday agreeing to pay Ethyl $13 million in damages and to cover the company's legal costs. It will also proclaim publicly that MMT is "safe" in direct contradiction of the view of its national environmental protection agency.

Trade negotiators in the U.S. and Canada have generally dismissed concerns that trade and investment agreements would have a "chilling effect" on public interest laws. The outcome of the Ethyl case demonstrates that corporations can and will use the rights granted to them under trade agreements to attack and in some cases eliminate public health and environmental laws.

If a country with the economic standing of Canada can be forced to repeal its public health laws, the threat is obvious for environmental and health and safety protections worldwide, including in the U.S.

Even before Ethyl forced Canada to dump its public health law, a more potent version of the NAFTA provision Ethyl employed had become one of the most controversial elements of the proposed Multilateral Agreement on Investment.

Copyright © 2010 Public Citizen. All rights reserved. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation.  Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.